tirzepatide glp1 and gip Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Tirzepatide, a dual GIP/GLP-1 receptor

Learn more and contact us today.

Trulicity is a prescription medication used to treat type 2 diabetes. It is in the class of drugs called GLP-1 receptor agonists and works by stimulating the release of insulin and decreasing the production of sugar by the liver. The pre-filled pens come in a pack of 4 and contain a solution of dulaglutide, the active ingredient, in a concentration of 1.5 mg per 0.5 mL. These pens are used to inject Trulicity subcutaneously (under the skin) once a week and are intended for single-use only. They are convenient and easy to use, allowing patients to self-administer their medication at home

Understanding Mounjaro and Its Uses Mounjaro is a medication that has gained attention for its effectiveness in managing certain health conditions, particularly type 2 diabetes

Food and Drug Administration (FDA) approved Wegovy (the brand name for once-weekly Semaglutide 2.4 mg injection) for chronic weight management

Gynecomastia forms a firm, rubbery mass directly beneath the nipple and does not resolve with diet or exercise